Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-25 @ 3:20 AM
NCT ID:
NCT00713505
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Childhood cancer survivor who received CNS-directed therapy (i.e., intrathecal chemotherapy and/or cranial radiotherapy) for leukemia or non-Hodgkin lymphoma
* In remission AND completed treatment ≥ 3 months ago
* No brain tumors
* Enrolled in school and demonstrates a deficit (operationalized as at least one standard deviation below the age expected mean) on at least one objective test of attention or memory on baseline cognitive assessment screening AND has evidence of problems in learning and adaptive functioning
* Parent, teacher, or self-report of problems as measured by a T-score of ≥ 60 on the BRIEF or BASC or below average academic achievement scores
* Able to be tested in English using standardized cognitive and academic achievement tools
PATIENT CHARACTERISTICS:
* Primary participating parent or caregiver fluent in English and lives with the child
* No known history of a major psychiatric condition (i.e., psychosis) that precludes study participation (child or participating parent or caregiver)
* No history of child developmental disability prior to cancer diagnosis
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
16 Years
Study:
NCT00713505
Study Brief:
Protocol Section:
NCT00713505